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Objective This report chronicles an outbreak of a multiply resistant strain of Pseudomonas aeruginosa and the
measures required to contain this outbreak.
Methods Laboratory-based ward-liaison surveillance allowed the detection of a multiply resistant strain of P.
aeruginosa infecting patients in our hematology/oncology unit. Sampling of the immediate environment was
carried out. Pulsed ﬁeld gel electrophoresis was used to compare the patients’ organisms with those found in
the environment. Extensive dismantling of the drainage system, repeated cleaning and disinfection, and a
review of the departmental antibiotic policy were some of the infection control measures instigated.
Results During a period of 11 months, three patients in the hematology department and two patients in the
oncology department were infected with multiply resistant P. aeruginosa. There were two cases of pneumonia,
one of which was fatal, and two cases of neutropenic septicaemia. Pulsed ﬁeld gel electrophoresis performed
on the isolates showed that the isolates from geographically separate areas could be divided into two strains that
were closely related but distinct. Two genotypically identical strains were also isolated from the plumbing
systems in the areas of each ward where patients had been treated.
Conclusion The potential for serious nosocomial infections with P. aeruginosa is well recognized. Eradication
of the organism from the environment may require the co-ordinated efforts of clinicians, nurses, pharmacy and
hospital engineers, working in collaboration with the hospital infection control team. To date, the same strains
have not been isolated despite repeated surveillance over the past 18months and therefore these measures have,
in our opinion, successfully removed the potential for nosocomial infection with this resistant organism in our
hospital.
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INTRODUCTION
As the number of immunosuppressed patients being treated
in hospital continues to increase, effective infection control
measures must be present to ensure that the level of nosocomial
infections is kept to a minimum. The empirical use of broad-
spectrum antibiotics in patients with febrile neutropenia may
lead to the selection of more resistant populations of organisms
and therefore adequate surveillance must be in place to detect
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the emergence of such resistant pathogens. Pseudomonas
aeruginosa is one such organism which may become resistant to
commonly used empirical antibiotics. The laboratory obser-
vation of similar antibiograms in two or more separate isolates
is often the ﬁrst indication that an episode of cross-infection
has occurred or that a common source for the organism exists.
Further conﬁrmation that identical strains are present relies on
more complex typing methods involving the determination
of phenotypic and, more recently, genotypic markers. DNA
fragmentation by endonuclease digestion followed by pulsed
ﬁeld gel electrophoresis (PFGE) has been shown to be a highly
discriminatory method of typing various organisms including
P. aeruginosa [1,2].
The environment (particularly sink drains and water outlets)
has previously been reported as a possible source in outbreaks
of infection with P. aeruginosa in intensive care and hematology
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wards [3]. Acquisition of environmental strains by the patient
may be associated with a poor prognosis. We report a cluster
of cases of infection with a multiply resistant organism which
was isolated from the patients’ close environment. This
occurred in a large teaching hospital over several months and
affected two separate wards which shared common features
of immunocompromised patients and an empirical antibiotic
policy. The episode highlights the fact that the eradication of
problematic bacterial strains may require the co-ordinated
efforts of medical, nursing and infection control staff and hos-
pital engineers.
METHODS
Clinical areas
Two separate wards were involved in this cluster of infections.
The hematology unit is a recently refurbished ward with single
rooms for source and protective isolation. Within this unit,
only two rooms were involved and both of these may be
supplied with HEPA ﬁltered air (although this is not always
used). The oncology unit is situated in a different part of the
hospital. No local plumbing or ventilation system serves both
areas. None of the patients on these wards require mechanical
ventilation.
Surveillance
A system of laboratory-based ward-liaison surveillance is in
place, where laboratory medical staff authorize all positive
reports before visiting the clinical areas.
Bacteriological culture
Clinical samples were collected and cultured by routine bac-
teriological methods. Isolates of P. aeruginosa were conﬁrmed
by growth at 42 °C and biochemical reactions (oxidase test and
API identiﬁcation system (bioMerieux, Lyon, France)).
Disc sensitivity testing of isolates was performed on Iso-
Sensitest agar. Antibiotic discs were obtained from Mast Diag-
nostics, Bootle, UK. After incubation for 18 h in air, plates
were read using a Radius semi-automated plate scanner (Mast
Diagnostics, Bootle, UK). Antibiotic sensitivity was determined
by the Kirby–Bauer method using NCCLS guidelines. The
initial antibiotics tested were ciproﬂoxacin, piperacillin-tazo-
bactam, ceftazidime, meropenem, gentamicin, and tobramycin.
Resistant isolates were then further tested against aztreonam,
piperacillin, amikacin and colistin. The minimum inhibitory
concentrations were tested for meropenem and ceftazidime by
Epsilometer-test (E test; Cambridge Diagnostics, Cambridge,
UK).
Isolates which were indistinguishable by their antibiograms
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and biochemical API proﬁle were stored on nutrient agar slopes
at 4 °C until further study.
Patient screening
Following detection of the resistant strain in clinical samples,
routine surveillance of patient samples was instituted in the
hematology department after an initial meeting between the
microbiology consultant, the infection control nurse and the
consultants and nursing staff in the hematology department. A
sample of faeces on admission and weekly samples while the
patient was in thewardwere cultured on Pseudomonas isolation
agar (Difco Labs, Detroit, MI, USA) in air overnight at 37 °C.
The colonies of P. aeruginosa were then screened for resistance
to piperacillin-tazobactam on Columbia blood agar on which
had been laid a piperacillin-tazobactam impregnated disc
(75/10 mg). Isolates showing resistance to this agent were then
tested against the other antibiotics listed above.
Environmental sampling
Themethod of detection of P. aeruginosawas similar to that used
for the patients’ samples. Plain cotton-tipped swabs without
transport medium were used. These were moistened in sterile
saline if the site being swabbed was found to be dry. The
outﬂows of all sinks, drains and shower-heads and taps were
sampled. Initially, swabs were taken from all such sites in both
wards. If the resistant strain had been detected by environmental
sampling, the patient in that room was screened to exclude
colonization with the same resistant organism. Sampling was
repeated 1 month later in the oncology department. Thereafter,
sampling was conﬁned to sites which had previously yielded a
positive result. In hematology, samples taken weekly from the
main ward area failed to grow the same resistant strain of P.
aeruginosa on three successive occasions. Thereafter, further
environmental sampling on a weekly basis was conﬁned to the
two isolation rooms which had yielded positive results. At
this stage, environmental sampling of the main ward area was
discontinued. A total of 195 environmental specimens were
collected during the incident.
Pulsed-ﬁeld gel electrophoresis
Isolates of appropriately resistant P. aeruginosa from patients’
clinical samples and from environmental sampling of both wards
were genotyped by PFGE using restriction enzyme XbaI. This
was performed by Dr J. R. W.Govan and Mrs C. Doherty of
the Department of Medical Microbiology, The University of
Edinburgh Medical School.
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Disinfection
Sinks and drains found to be positive were dismantled, cleaned
with hot water and detergent, then dried before disinfection.
One litre of 10 000 p.p.m. sodium hypochlorite was poured
into the drain and left for 30min then ﬂushed with running
water. Further rinses were performed hourly for the next 8 h.
RESULTS
None of the patients’ faecal samples on admission yielded P.
aeruginosa with a similar antibiogram. The ﬁve patients from
whom multiply resistant P. aeruginosa was isolated are listed in
Table 1. The two patients in ward 5 were not nursed in the
same room. Several months elapsed between the ﬁrst detection
of the organism and subsequent isolation from other patients.
Environmental sampling was instigated after two patients who
had been in the same room in ward 8 (room 6) were found
to have been infected with apparently identical strains of P.
aeruginosa.
The occasions when environmental surveillance of ward 8
detected a piperacillin-tazobactam resistant P. aeruginosa with
the same antibiogram are shown in Table 2. Attempted dis-
infection of the drains was being performed throughout this
time on the dates listed.
Environmental sampling of ward 5 was started after the
isolation of the similar multiply resistant strain from two pati-
ents. Piperacillin-tazobactam resistant P. aeruginosa detected by
environmental sampling in ward 5 are listed in Table 3. Again,
disinfection of the drains was carried out after a positive result
from an environmental sample.
Sensitivity testing
All piperacillin-tazobactam resistant isolates were sensitive to
ceftazidime, meropenem and amikacin, but were resistant to all
other agents tested.
Table 1 Details of patients from whom multiply resistant P. aeruginosa was isolated
Patient Initials Ward/room Date ﬁrst isolated Site Clinical progress
1 M.H. 8/6 2 February 1997 Sputum Allogeneic bone marrow transplant (BMT) for chronic
myeloid leukaemia – profoundly neutropenic nosocomial
pneumonia – died
2 K.W. ward 5 18 July 1997 Blood Neutropenic sepsis – recovered on appropriate therapy
3 S.M. 8/6: 26 July 1997 Blood Allogeneic BMT for very severe aplastic anaemia –
room 5 on 30 July 1997 profoundly neutropenic, line-associated septicaemia –
recovered on appropriate therapy
4 E.W. ward 5 6 August 1997 Line tip Hickman line colonization – detected upon removal
5 P.B. 8/5 24 August 1997 Sputum Autologous PBSC transplant for mantle cell lymphoma –
profoundly neutropenic, nosocomial pneumonia –
recovered on appropriate therapy
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The minimum inhibitory concentration of ceftazidime by E
test was increased (2mg/L) in comparison with a fully sensitive
control (P. aeruginosa NCTC 10662) but this minor alteration
was not detectable by disc sensitivity testing. The sensitivity to
meropenem was unchanged by disc sensitivity testing and by E
test.
Typing results
PFGE allowed the isolates to be separated into two distinct
groups (data not shown). Those from ward 8 patients and from
the environmental samples from rooms 5 and 6 in ward 8 could
be grouped together with identical PFGE proﬁles. Another
group, consisting of the patient isolates and the environmental
isolates from ward 5, possessed a dissimilar PFGE proﬁle which
differed from that of the former group by three bands. This is
consistent with two closely related but separate strains being
present, as a single point mutation could produce a three-band
difference [4]. The remaining piperacillin-tazobactam resistant
isolates had unique PFGE proﬁles which were distinct from
either of the other two strains.
DISCUSSION
The strain of P. aeruginosa involved in this investigation was
able to cause serious morbidity andmortality in this neutropenic
population; being isolated from blood cultures, sputum, an
intravenous catheter tip and being the cause of a fatal noso-
comial pneumonia in one patient. The recurrent isolation of
the same multiply resistant strain of P. aeruginosa over several
months led us to suspect that an environmental site was the
continuing source of this organism. Results obtained from pre-
liminary environmental swabbing indicated that the P. aeru-
ginosa strain could be isolated from the drainage system but not
from the water supply or ﬁttings. Previously, when drains have
been implicated as a source of the offending organism, splash-
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Table 2 Results of screening the
environment in ward 8 Date Ward/room Site Result
30 July 1997 8/6 Main room sink outlet PTZ-R Paera
(patient S.M. moved En-suite sink outlet PTZ-R Paer
to room 5)
5 August 1997 Main room and en-suite sink outlets dismantled,
cleaned and disinfected
27 August 1997 8/6 Main room sink outlet PTZ-R Paer
29 August 1997 Main room and en-suite sink outlets dismantled,
cleaned and disinfected
3 September 1997 8/5 Toilet bowl PTZ-R Paer
9 September 1997 Room 5 Toilet bowl dismantled, cleaned and
disinfected
29 October 1997 8/6 En-suite sink outlet PTZ-R Paer
6 November 1997 8 Nurses’ sink drain in wardb PTZ-R Paer
6 November 1997 Nurses’ sink and en-suite sink outlets dismantled,
cleaned and disinfected
26 November 1997 Nurses’ sink and en-suite sink outlets dismantled,
cleaned and disinfected
15 January 1998 8/6 En-suite sink outlet PTZ-R Paer
17 January 1998 Nurses’ sink and en-suite sink outlets dismantled,
cleaned and disinfected
January–July 1998 Continued monthly sampling of ward and weekly
sampling of positive areas
2 July 1998 8 PTZ-R Paer
5 July 1998 Drain outside room 6 cleaned and disinfected
20 July 1998 8 Drain outside room 6 PTZ-R Paer
8/6 En-suite sink outlet PTZ-R Paer
23 July 1998 Both drain pipes replaced and straightened
a PTZ-R Paer, piperacillin-tazobactam-resistant P. aeruginosa.
b The nurses’ sink in the main ward and the en-suite sink in room 6 shared a common outﬂow.
Table 3 Environmental samples from ward 5
Date Room Site Result
22 August 1997 3–6 Shower drain PTZ-R Paera
6 Sink drain PTZ-R Paer
Main ward Sluice sink PTZ-R Paer (different PFGE proﬁle)
Main ward Sluice sink PTZ-R Paer
Main ward Sink PTZ-R Paer
Main ward Disabled toilet sink PTZ-R Paer
Main ward Shower drain PTZ-R Paer
29 August 1997 3–6 No PTZ-R Paer
5 September 1997 All areas No PTZ-R Paer
7 October 1997 All areas No PTZ-R Paer
4 November 1997 Main ward Shower drain PTZ-R Paer (different PFGE proﬁle)
November 1997– Weekly sampling until January 1998 then continued monthly
September 1998
22 September 1998 Ten various sites positive in ward and room drains PTZ-R Paer
30 September 1998 All positive sites treated with 10000p.p.m. hypochlorite
8 October 1998 Six various sites positive PTZ-R Paer (two isolates’ sensitivity pattern
differed only with respect to meropenem
resistance, but all with same PFGE proﬁle
15 October 1998 All positive sites treated with 10000p.p.m. hypochlorite
4 November 1998 All sites negative
and subsequently
a PTZ-R Paer, piperacillin-tazobactam-resistant P. aeruginosa.
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back and regurgitation have been assumed to be the cross-
infection hazard [3]. In our cluster, these events were not
observed to occur. Indeed, there is no unequivocal proof that
the environment did not become colonized from patients and
a separate, undetected mechanism of cross-infection was occur-
ring. However, a patient (S.M.) in ward 8, who was known to
be excreting the organism, was moved from room 6 to room
5, 2 months before another patient in room 5 became infected
(P.B.). Environmental screening of hospital wards has pre-
viously detected resistant micro-organisms which have been
implicated in episodes of nosocomial infection [5]. The eradi-
cation of these organisms from a particular site may require, as
in this instance, the co-ordinated efforts of the infection control
team, ward staff and engineers. Because of the possibility of
further episodes of nosocomial infection, it was considered
justiﬁable to attempt to remove the potential environmental
source.
The initial failure to eradicate the organism by cleaning and
disinfection was assumed to be due to persistence of drainage
sludge providing a protected environment for the organism. As
a result, a structural review of the plumbing system and repeated
dismantling and disinfection of drains by the hospital works
department was performed in both wards. Throughout this
time, the overall cost of laboratory consumables required in
the processing of surveillance samples received was increased.
Simultaneously, a review of the departmental antibiotic policy
was made. Regular rotation of the antibiotics contained within
a hospital’s (or a department’s) antibiotic policy has been re-
commended previously [6], although antibiotic rotation may
not prevent the selection of resistant bacterial strains if gen-
etically linked cross-resistance across different antibiotic classes
is present. Although this organism was found to be resistant to
both of the antibiotics used as ﬁrst line in the department, the
decision was made to alter only one of the antibiotics as the
isolation of the organism from patients was uncommon, and the
majority of other Gram-negatives isolated in the unit remained
sensitive to both.
The demonstration by PFGE of two closely related, but
distinct, strains of P. aeruginosa from the two physically separate
ward areas is interesting and suggests the interaction of cross-
infection and antibiotic-driven selection of resistance. As the
two affected areas are geographically unlinked, an unidentiﬁed
member of the hospital staff may have carried the organism
between the two wards. We suspect that a mutation in one of
the strains could then have conferred the minor difference in
PFGE proﬁles. The use of prophylactic ciproﬂoxacin during
neutropenia and similar ﬁrst-line antibiotic agents in both clini-
cal areas (piperacillin-tazobactam + gentamicin) subsequently
produced similar selection pressures resulting in the selection
of the related ancestral strains in both units. Meropenem sen-
sitivity was not consistent within one of the clones, a later
isolate from the environment in ward 5 having developed
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resistance to this agent. Fortunately, a strain with this particular
sensitivity pattern was not isolated from a patient as the range
of available treatment options would be narrow.
Resistance in this organism involved several structurally
unrelated classes of antibiotics. This may possibly result from
an alteration in the permeability of the porin channels on the
outer membrane or an increased efﬂux of antibiotics via the
MexA-MexB-OprM pump (or a combination of both) [7,8].
The pattern and degree of resistance to the beta-lactam agents
would be consistent with the selection of a strain possessing a
partially induced or stably derepressed-chromosomal AmpC
beta-lactamase [9]. It is possible that several distinct mechanisms
to include the other antibiotic classes may be involved.
Although a single plasmid which possesses several genes that
confer resistance to different classes of antibiotics might be
present we feel this unlikely as plasmid-mediated quinolone
resistance has not been described and is unlikely since the wild-
type gene for DNA gyrase would still be able to function. The
pattern of resistance is similar to that possessed by a strain of P.
aeruginosa reported in an outbreak involving patients and the
environment in a French hospital in 1998 [10]. In that example
the mechanism of resistance to a number of antibiotics was
found to be associated with an outer membrane protein causing
increased efﬂux of drugs from the peri-plasmic space.
This report cannot prove that the infection control measures
taken were solely responsible for the eradication of this resistant
strain, although we feel that this is likely. Our experience with
this cluster of isolates highlights the importance of constant
surveillance of the patterns of resistance amongst organisms in
a hospital and the value of accurate typingmethods to determine
cross-relatedness of bacterial strains. The potential of environ-
mental organisms to infect susceptible patients should not be
forgotten and ward procedures should be implemented to pre-
vent cross-infection where possible. With increasing use of
broad-spectrum antibiotics, surveillance activity to detect mul-
tiply resistant strains must continue to be the normal practice
of infection control staff. The continuing value of laboratory-
based ward-liaison surveillance should not be underestimated.
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